7795 related articles for article (PubMed ID: 2513378)
1. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
Gridley DS; Slater JM; Stickney DR
J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
Trotta PP; Harrison SD
Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
[TBL] [Abstract][Full Text] [Related]
3. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
Huang P; Allam A; Perez LA; Taghian A; Freeman J; Suit HD
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):93-8. PubMed ID: 7721643
[TBL] [Abstract][Full Text] [Related]
4. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.
Balkwill FR; Lee A; Aldam G; Moodie E; Thomas JA; Tavernier J; Fiers W
Cancer Res; 1986 Aug; 46(8):3990-3. PubMed ID: 2425938
[TBL] [Abstract][Full Text] [Related]
5. Effects of tumour necrosis factor on human tumour xenografts in nude mice.
Balkwill FR; Ward BG; Fiers W
Ciba Found Symp; 1987; 131():154-69. PubMed ID: 3131073
[TBL] [Abstract][Full Text] [Related]
6. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
Klapdor R; Schwarzenberg O; Kühl JS; Franke N; Bahlo M
Strahlenther Onkol; 1989 Jul; 165(7):549-50. PubMed ID: 2501886
[No Abstract] [Full Text] [Related]
7. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
Balkwill FR; Ward BG; Moodie E; Fiers W
Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM
Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567
[TBL] [Abstract][Full Text] [Related]
11. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y
Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050
[TBL] [Abstract][Full Text] [Related]
12. Interferon enhancement of radioimmunotherapy for colon carcinoma.
Kuhn JA; Beatty BG; Wong JY; Esteban JM; Wanek PM; Wall F; Buras RR; Williams LE; Beatty JD
Cancer Res; 1991 May; 51(9):2335-9. PubMed ID: 1901760
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
[TBL] [Abstract][Full Text] [Related]
15. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
16. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
17. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
20. VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha.
Renard N; Nooijen PT; Schalkwijk L; De Waal RM; Eggermont AM; Liénard D; Kroon BB; Lejeune FJ; Ruiter DJ
J Pathol; 1995 Jul; 176(3):279-87. PubMed ID: 7674090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]